Open AccessRituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY
Author(s) -
Nattawat Klomjit,
Ladan Zand
Publication year - 2021
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0002492021
Subject(s) - cyclophosphamide , rituximab , medicine , membranous nephropathy , nephropathy , immunology , antibody , glomerulonephritis , kidney , chemotherapy , endocrinology , diabetes mellitus
This is an Early Access article. Please select the PDF button, above, to view it.Be sure to also read the PRO: 10.34067/KID.0001842021 and the CON: 10.34067/KID.0001432021
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom